REDMOND, Wash., Feb. 15, 2018 -- MicroVision, Inc. (NASDAQ:MVIS), a leader in innovative ultra-miniature projection display and sensing technology, today announced that it will report results for its fourth quarter 2017 after the market closes on Thursday, Feb. 22, 2018. Following the issuance of the company’s financial results press release, interested parties can listen to the company's conference call which will start at 5:00 p.m. ET/2:00 p.m. PT by accessing the Investor Relations’ section of MicroVision’s web site on the Investor Events Calendar page or dialing 1-877-883-0383 (for U.S. participants) or 1-412-902-6506 (for international participants) ten minutes prior to the start of the call using pass code number 7974982. A replay webcast of the call will also be available from the Investor Relations’ section of MicroVision’s web site on the Investor Events Calendar page.
About MicroVision
MicroVision is the creator of PicoP® scanning technology, an ultra-miniature laser projection and sensing solution for mobile consumer electronics, automotive head-up displays and other applications. MicroVision’s patented technology is a single platform that can enable projected displays, image capture and interaction for a wide array of future-ready products in this rapidly evolving, always-on world. Extensive research has led MicroVision to become an independently recognized leader in the development of intellectual property. MicroVision’s IP portfolio has been recognized by the Patent Board as a top 50 IP portfolio among global industrial companies and has been included in the Ocean Tomo 300 Patent Index. The company is based in Redmond, Wash.
For more information, visit the company’s website at www.microvision.com, on Facebook at www.facebook.com/microvisioninc or follow MicroVision on Twitter at @MicroVision.
MicroVision and PicoP are trademarks of MicroVision, Inc. in the United States and other countries. All other trademarks are the properties of their respective owners.
Forward-Looking Statements
Certain statements contained in this release, including those relating to future product and product applications are forward-looking statements that involve risks and uncertainties. Factors that could cause actual results to differ materially from those projected in the company's forward-looking statements include the following: our ability to raise additional capital when needed; products incorporating our PicoP display technology may not achieve market acceptance, commercial partners may not perform under agreements as anticipated, we may be unsuccessful in identifying parties interested in paying any amounts or amounts we deem desirable for the purchase or license of IP assets, our or our customers failure to perform under open purchase orders; our financial and technical resources relative to those of our competitors; our ability to keep up with rapid technological change; government regulation of our technologies; our ability to enforce our intellectual property rights and protect our proprietary technologies; the ability to obtain additional contract awards; the timing of commercial product launches and delays in product development; the ability to achieve key technical milestones in key products; dependence on third parties to develop, manufacture, sell and market our products; potential product liability claims; and other risk factors identified from time to time in the company's SEC reports, including the company's Annual Report on Form 10-K filed with the SEC. Except as expressly required by federal securities laws, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changes in circumstances or any other reason.
Investor Relations Contacts:
Ted Moreau
Darrow Associates, Inc.
608.298.7369
[email protected]
or
David H. Allen
Darrow Associates, Inc.
408.427.4463
[email protected]


Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
How Marco Pharma International Preserves German Homeopathic Traditions in America
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks
Gates Foundation Denies Financial Ties to Jeffrey Epstein Following DOJ Email Release
FTC Questions Apple News Over Alleged Bias Against Conservative Media
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
Spirit Airlines Seeks Court Approval to Auction 20 Airbus A320/A321 Aircraft Amid Bankruptcy
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
ANZ Shares Hit Record High After Strong Q1 Profit and Cost-Cutting Gains
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide 



